Summit Financial, LLC Novartis Ag Transaction History

Summit Financial, LLC

$2.54 Billion
Q3 2024

A detailed history of Summit Financial, LLC transactions in Novartis Ag stock. As of the latest transaction made, Summit Financial, LLC holds 3,790 shares of NVS stock, worth $375,589. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,790

Previous 3,451 9.82%

Holding current value

$375,589

Previous $367,000 18.53%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $35,978 - $40,981	339 Added 9.82%	3,790 $435,000
Q2 2024 Jul 31, 2024	SELL	$92.57 - $107.37 $8,423 - $9,770	-91 Reduced 2.57%	3,451 $367,000
Q1 2024 Apr 24, 2024	SELL	$95.27 - $108.47 $141,666 - $161,294	-1,487 Reduced 29.57%	3,542 $342,000
Q4 2023 Feb 05, 2024	BUY	$92.27 - $101.54 $35,800 - $39,397	388 Added 8.36%	5,029 $507,000
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $378 - $420	4 Added 0.09%	4,641 $472,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $90,762 - $102,916	981 Added 26.83%	4,637 $467,000
Q1 2023 May 03, 2023	SELL	$80.03 - $92.81 $119,964 - $139,122	-1,499 Reduced 29.08%	3,656 $336,000
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $327,433 - $400,981	-4,334 Reduced 45.67%	5,155 $467,000
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $64,985 - $76,003	871 Added 10.11%	9,489 $721 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $116,673 - $135,843	-1,449 Reduced 14.39%	8,618 $728,000
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $106,305 - $120,252	1,327 Added 15.18%	10,067 $883,000
Q4 2021 Feb 07, 2022	BUY	$79.7 - $88.13 $187,852 - $207,722	2,357 Added 36.93%	8,740 $764,000
Q3 2021 Nov 08, 2021	BUY	$81.78 - $95.14 $251,228 - $292,270	3,072 Added 92.78%	6,383 $522,000
Q2 2021 Aug 06, 2021	BUY	$85.24 - $94.15 $282,229 - $311,730	3,311 New	3,311 $302,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.

Account

Summit Financial, LLC Novartis Ag Transaction History